The Biotech Stock Safety Net


Call it the Pfizer put. The giant pharmaceutical company sold €4 billion ($4.22 billion) in bonds this week, paying a yield of almost nothing.The ease and low cost of Pfizer’s borrowing shows that it or any of its major rivals could easily fund the acquisition of almost any biotech.

Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *

Home / Home Left / The Biotech Stock Safety Net